Search results for "VTE"
November 2011
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2011/11/
Unfractionated heparin may be underprescribed in obese patients with VTE
Obese patients may not receive correct weight-based doses of unfractionated heparin for venous thromboembolism (VTE), according to a new single-site study.
https://acphospitalist.acponline.org/weekly/archives/2011/04/27/5.htm
27 Apr 2011
April 2007
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2007/04/
Infection, other factors may increase risk for VTE hospitalization
Infection, treatment with erythropoiesis-stimulating agents, and blood transfusion may increase risk for hospitalization due to venous thromboembolism (VTE), according to a new study.
https://acphospitalist.acponline.org/weekly/archives/2012/04/11/2.htm
11 Apr 2012
For inpatient VTE prevention, rivaroxaban noninferior to enoxaparin
Rivaroxaban is noninferior to enoxaparin for standard-duration venous thromboembolism (VTE) prophylaxis in acutely ill patients, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2013/02/13/3.htm
13 Feb 2013
Oral anticoagulants compared for risk of recurrent VTE, major bleeds
All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a meta-analysis found.
https://acphospitalist.acponline.org/weekly/archives/2013/09/11/4.htm
11 Sep 2013
August 2007
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2007/08/
UFH, LMWH similar in cost, efficacy for VTE prophylaxis
Unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) have similar costs and effectiveness for venous thromboembolism (VTE) prophylaxis, but LMWH is associated with fewer complications, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2012/04/11/3.htm
11 Apr 2012
January 2012
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2012/01/
Aspirin noninferior to dalteparin for VTE prophylaxis following hip replacement
Aspirin therapy for 28 days may be a reasonable alternative to low-molecular-weight heparin (LMWH) for extended venous thromboembolism (VTE) prophylaxis among hip replacement patients who have already received LMWH for 10 days.
https://acphospitalist.acponline.org/weekly/archives/2013/06/05/2.htm
5 Jun 2013